[Fibrinolytic treatment of myocardial infarction. Agents, indications, complications].
Curyło
A M
AM
I Kliniki Kardiologii IK AM, Krakowie.
D000368:Aged; D016255:Anistreplase / Q000008:administration & dosage; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D013300:Streptokinase / Q000008:administration & dosage; D015912:Thrombolytic Therapy / Q000009:adverse effects; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage
D016255:Anistreplase; D013300:Streptokinase; D010959:Tissue Plasminogen Activator
Leczenie fibrynolityczne w zawale serca. Leki, wskazania, powikłania.